Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1998 Jul;36(7):2143-5.
doi: 10.1128/JCM.36.7.2143-2145.1998.

Line probe assay for detection of human immunodeficiency virus type 1 mutations conferring resistance to nucleoside inhibitors of reverse transcriptase: comparison with sequence analysis

D Descamps  1 , V Calvez, G Collin, A Cécille, C Apetrei, F Damond, C Katlama, S Matheron, J M Huraux, F Brun-Vézinet
Affiliations
Clinical Trial

Line probe assay for detection of human immunodeficiency virus type 1 mutations conferring resistance to nucleoside inhibitors of reverse transcriptase: comparison with sequence analysis

D Descamps et al. J Clin Microbiol. 1998 Jul.

Abstract

We compared the line probe assay (LiPA) to sequence analysis for the detection of mutations conferring resistance to nucleoside inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT). Plasma samples from 40 patients who had received zidovudine, dideoxyinosine, and dideoxycytosine, alone or in combination, and who were enrolled in the ALTIS 2 clinical trial (lamivudine [3TC] plus stavudine) were tested at enrollment and at week 24. RT PCR products from plasma were used for LiPA, and DNA was used for sequence analysis. LiPA gave uninterpretable results for 8.5% of the analyzed codons corresponding to 63 samples, mainly for codons 41, 69, and 70. Several minor discrepancies between the two methods occurred, mainly due to the ability of LiPA to detect mixed populations while sequence analyses detect a single homogeneous population. LiPA is suitable for detecting mixed populations and easy to implement in clinical laboratories and might be useful for epidemiological surveys of primary HIV-1 resistance.

PubMed Disclaimer

References

    1. BHIVA Guidelines Co-ordinating Committee. British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. Lancet. 1997;349:1086–1092. - PubMed
    1. Brun-Vézinet F, Ingrand D, Deforges L, Gochi K, Ferchal F, Schmitt M-P, Jung M, Masquelier B, Aubert J, Buffer-Janvresse C, Fleury H. HIV-1 sensitivity to zidovudine: a consensus culture technique validated by genotypic analysis of the reverse-transcriptase. J Virol Methods. 1991;37:177–188. - PubMed
    1. Carpenter C C J, Fischl M A, Hammer S M, Hirsch M S, Jacobsen D A, Katzenstein D A, Montaner J S G, Richman D D, Saag M S, Schooley R T, Thompson M A, Vella S, Yeni P G, Volberding P A. Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. JAMA. 1996;276:146–154. - PubMed
    1. Carpenter C C J, Fischl M A, Hammer S M, Hirsch M S, Jacobsen D A, Katzenstein D A, Montaner J S G, Richman D D, Saag M S, Schooley R T, Thompson M A, Vella S, Yeni P G, Volberding P A. Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel. JAMA. 1997;277:1962–1969. - PubMed
    1. Chomcyznski P, Sacci N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156–159. - PubMed

Publication types

MeSH terms